Hookipa Pharma

IPO

New York, United States · Founded 2011 · $159.8M raised

Headquarters
New York, New York
Employees
51–200
Founded
2011
Business Model
B2B
Total Funding
$159.8M
Last Round
$21.3M Corporate RoundDec 2023
Rounds
5

About

HOOKIPA Pharma (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing immunotherapy through proprietary arenavirus vector platforms. Its replication-restricted and replication-competent arenaviral vectors are engineered to generate strong and durable T-cell responses, addressing cancers and chronic infectious diseases such as HIV. The company's pipeline includes HB-200 (HPV16+ head and neck cancer, in combination with pembrolizumab) and HB-300 (prostate cancer targeting self-antigens), both in Phase 2 trials. Founded in 2011 and headquartered in New York City, HOOKIPA was spun out of leading academic research and has raised approximately $160M to advance its novel immunotherapy pipeline.

Summary

Hookipa Pharma is a Biotech company based in New York, United States, founded in 2011. It has raised $159.8M in total across 5 rounds, most recently a $21.3M Corporate Round round in Dec 2023. Investors include Redmile Group, Forbion Capital Partners and Sofinnova Partners.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundCorporate RoundDec 2023
$21.3M

Sign up to see all 6 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hookipa Pharma on Indexed.vc
<a href="https://indexed.vc/companies/hookipa-pharma"><img src="https://indexed.vc/api/badge/company/hookipa-pharma" alt="Hookipa Pharma on Indexed.vc" width="260" height="76" /></a>